Trademark Overview
On Thursday, August 1, 2024, a trademark application was filed for PLURALINK with the United States Patent and Trademark Office. The USPTO has given the PLURALINK trademark a serial number of 98677579. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, August 1, 2024. This trademark is owned by The Board of Regents of the University of Texas System. The PLURALINK trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:
Pharmaceutical products for cell therapy; cells and cell lines for medical or clinical use; cellular pharmaceutical preparations for use in oncology; natural killer (NK) cell preparations for clinical use, medical use, and laboratory use; pharmaceutical preparations in the nature of systems and cells used to deliver modified genetic material into other cells for medical purposes; kits comprised of cell-derived preparations, namely, natural killer cell or other immune cell-derived preparations for clinical, medicinal, or therapeutic use
Licensing of intellectual property
Medical and scientific research; cell therapy research and development; scientific and technological services, namely, research, analysis and testing in the field of oncology, cell therapy, and immuno-oncology